Alumis Inc (ALMS)

May 01, 2026

ALMS Earnings History & Surprises | EPS & Revenue Results | ALUMIS INC (NASDAQ:ALMS) - ChartMill

May 01, 2026

Apr 28, 2026

Alumis Inc: Year-End 2025 Financial Results and Strategic TYK2 Pipeline Outlook - AlphaStreet

Apr 28, 2026

Apr 26, 2026

Why is ALMS stock rising today? - MSN

Apr 26, 2026

Apr 25, 2026

ALMS Price Today: Alumis Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 25, 2026

Apr 23, 2026

Why Alumis Inc. Stock Is Surging Higher Now - TipRanks

Apr 23, 2026

Apr 22, 2026

ALMS Financials: Income Statement, Balance Sheet & Cash Flow | Alumis Inc - Stock Titan

Apr 22, 2026

Apr 21, 2026

Why Alumis Inc. Shares Are Surging Today - TipRanks

Apr 21, 2026

Apr 20, 2026

Alumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 20, 2026

Apr 16, 2026

Alumis Inc. (NASDAQ:ALMS) Short Interest Up 25.3% in March - MarketBeat

Apr 16, 2026

Apr 16, 2026

Saturn V Capital Management LP's Alumis Inc(ALMS) Holding History - GuruFocus

Apr 16, 2026

Apr 15, 2026

Morgan Stanley Resumes Coverage of Alumis (ALMS) with $23 PT - MSN

Apr 15, 2026

Apr 15, 2026

Compelling Efficacy and Safety of Alumis’s Oral TYK2 Candidate Envu Underpins Buy Rating and $25 Target - TipRanks

Apr 15, 2026

Apr 15, 2026

H.C. Wainwright reiterates Alumis stock rating, $25 target By Investing.com - Investing.com Australia

Apr 15, 2026

Apr 15, 2026

H.C. Wainwright reiterates Alumis stock rating, $25 target - Investing.com

Apr 15, 2026

Apr 15, 2026

H.C. Wainwright Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $25 - Moomoo

Apr 15, 2026

Apr 14, 2026

The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight - GlobeNewswire Inc.

Apr 14, 2026

Apr 10, 2026

Raymond James and Guggenheim stay bullish on Alumis (ALMS) after trial results - MSN

Apr 10, 2026

Apr 10, 2026

Quarterly Earnings: Is Alumis Inc in a consolidation phaseProduct Launch & Daily Stock Trend Watchlist - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Alumis Inc. $ALMS Shares Sold by Trium Capital LLP - MarketBeat

Apr 10, 2026

Apr 09, 2026

How Investors Are Reacting To Alumis (ALMS) Psoriasis Drug’s Strong Phase 3 Data And Safety Profile - simplywall.st

Apr 09, 2026

Apr 09, 2026

ALUMIS INC. unveils psoriasis treatment isolating effects to immune cells only - Traders Union

Apr 09, 2026

Apr 07, 2026

Deep Track files Schedule 13G reporting 7.36M shares in ALMS (ALMS) - Stock Titan

Apr 07, 2026

Apr 07, 2026

Risk Analysis: Is Alumis Inc gaining market shareQuarterly Profit Review & High Return Trade Opportunity Guides - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Alumis Inc. (ALMS) stock price, news, quote and history - Yahoo Finance UK

Apr 06, 2026

Apr 06, 2026

Raymond James and Guggenheim Stay Bullish on Alumis (ALMS) After Trial Results - Yahoo Finance

Apr 06, 2026

Apr 06, 2026

Alumis (NASDAQ:ALMS) Shares Down 4.1%Here's What Happened - MarketBeat

Apr 06, 2026

Apr 06, 2026

Why Alumis Inc. Stock Is Dropping After Good News - TipRanks

Apr 06, 2026

Apr 06, 2026

Form 8-KCurrent report - ADVFN

Apr 06, 2026

Apr 06, 2026

Why is Alumis stock falling Monday? - MSN

Apr 06, 2026

Apr 05, 2026

10 Best Performing Stocks of Q1 2026 to Watch for Q2 - Insider Monkey

Apr 05, 2026

Apr 05, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Apr 05, 2026

Apr 04, 2026

Why Alumis (ALMS) Is Down 5.8% After Positive Phase 3 Psoriasis Data And NDA Plans - Yahoo Finance

Apr 04, 2026

Apr 03, 2026

Alumis (ALMS) Valuation Check After Positive Phase 3 Psoriasis Results For Envudeucitinib - Yahoo Finance

Apr 03, 2026

Apr 03, 2026

Foresite entities move ALUMIS (ALMS) shares in pro rata in-kind distributions - Stock Titan

Apr 03, 2026

Apr 03, 2026

Foresite funds realign Alumis (ALMS) stakes via in-kind distributions - Stock Titan

Apr 03, 2026

Apr 03, 2026

Alumis (ALMS) insider-linked entities shift 4.1M shares via in-kind distributions - Stock Titan

Apr 03, 2026

Apr 03, 2026

Tananbaum-led funds update Alumis (ALMS) ownership and 13D stake - Stock Titan

Apr 03, 2026

Apr 03, 2026

ALMS Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026

Apr 03, 2026

Why Alumis (ALMS) Is Down 8.4% After Positive Phase 3 Psoriasis Data And FDA Filing Plans - Sahm

Apr 03, 2026

Apr 02, 2026

ALMS SEC FilingsAlumis Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Apr 01, 2026

Why Alumis Inc. Shares Are Suddenly Surging - TipRanks

Apr 01, 2026

Apr 01, 2026

HC Wainwright Brokers Raise Earnings Estimates for Alumis - marketbeat.com

Apr 01, 2026

Mar 31, 2026

Alumis (NASDAQ:ALMS) Trading 12.1% Higher Following Analyst Upgrade - MarketBeat

Mar 31, 2026

Mar 31, 2026

Analysts Are Bullish on These Healthcare Stocks: Alumis Inc. (ALMS), Aquestive Therapeutics (AQST) - The Globe and Mail

Mar 31, 2026

Mar 31, 2026

AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases - BioSpace

Mar 31, 2026

Mar 31, 2026

FY2027 Earnings Estimate for Alumis Issued By HC Wainwright - MarketBeat

Mar 31, 2026

Mar 31, 2026

Alumis Furthers Its Case In TYK2 Race With Phase III Envudeucitinib Data - Citeline News & Insights

Mar 31, 2026

Mar 30, 2026

Oppenheimer Raises Price Target for ALMS, Maintains Outperform R - gurufocus.com

Mar 30, 2026

Mar 30, 2026

Alumis (ALMS): HC Wainwright & Co. Lowers Price Target, Maintains Buy Rating | ALMS Stock News - GuruFocus

Mar 30, 2026